Semanteon Capital Management LP bought a new stake in Waters Co. (NYSE:WAT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,527 shares of the medical instruments supplier’s stock, valued at approximately $832,000.
Several other hedge funds and other institutional investors have also made changes to their positions in WAT. London Co. of Virginia acquired a new stake in shares of Waters in the third quarter valued at about $158,723,000. Nordea Investment Management AB lifted its holdings in shares of Waters by 129.9% in the fourth quarter. Nordea Investment Management AB now owns 973,537 shares of the medical instruments supplier’s stock valued at $322,017,000 after purchasing an additional 550,112 shares in the last quarter. Findlay Park Partners LLP purchased a new stake in shares of Waters in the third quarter valued at about $78,017,000. American Century Companies Inc. lifted its holdings in shares of Waters by 34.3% in the third quarter. American Century Companies Inc. now owns 832,895 shares of the medical instruments supplier’s stock valued at $228,388,000 after purchasing an additional 212,754 shares in the last quarter. Finally, Fenimore Asset Management Inc. purchased a new stake in shares of Waters in the third quarter valued at about $50,897,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.
Insider Activity at Waters
In other Waters news, Director Linda Baddour sold 500 shares of the stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total transaction of $177,770.00. Following the transaction, the director now directly owns 2,250 shares in the company, valued at approximately $799,965. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.82% of the company’s stock.
Waters Stock Up 1.0 %
Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. The business had revenue of $819.50 million during the quarter, compared to analyst estimates of $815.50 million. Waters had a net margin of 21.72% and a return on equity of 81.30%. The business’s revenue was down 4.5% on a year-over-year basis. During the same period last year, the business earned $3.84 EPS. As a group, analysts forecast that Waters Co. will post 11.89 earnings per share for the current fiscal year.
Analysts Set New Price Targets
WAT has been the subject of several research analyst reports. Barclays upped their price target on shares of Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a research report on Monday, February 12th. Stifel Nicolaus upped their price target on shares of Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research report on Wednesday, February 7th. Finally, Evercore ISI upped their price target on shares of Waters from $320.00 to $340.00 and gave the stock an “in-line” rating in a research report on Thursday, April 4th. One analyst has rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. Based on data from MarketBeat, Waters presently has a consensus rating of “Hold” and an average price target of $298.67.
View Our Latest Analysis on Waters
Waters Company Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Five stocks we like better than Waters
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Stocks Leading the U.S. Agriculture Comeback
- With Risk Tolerance, One Size Does Not Fit All
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.